Correlation Between Talis Biomedical and NanoVibronix

Can any of the company-specific risk be diversified away by investing in both Talis Biomedical and NanoVibronix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talis Biomedical and NanoVibronix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Talis Biomedical Corp and NanoVibronix, you can compare the effects of market volatilities on Talis Biomedical and NanoVibronix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talis Biomedical with a short position of NanoVibronix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talis Biomedical and NanoVibronix.

Diversification Opportunities for Talis Biomedical and NanoVibronix

-0.49

Correlation Coefficient

Talis Biomedical  NanoVibronix

Very good diversification

The 3 months correlation between Talis and NanoVibronix is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Talis Biomedical Corp and NanoVibronix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NanoVibronix and Talis Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talis Biomedical Corp are associated (or correlated) with NanoVibronix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NanoVibronix has no effect on the direction of Talis Biomedical i.e., Talis Biomedical and NanoVibronix go up and down completely randomly.

Pair Corralation between Talis Biomedical and NanoVibronix

Given the investment horizon of 90 days Talis Biomedical Corp is expected to generate 0.67 times more return on investment than NanoVibronix. However, Talis Biomedical Corp is 1.49 times less risky than NanoVibronix. It trades about 0.11 of its potential returns per unit of risk. NanoVibronix is currently generating about -0.05 per unit of risk. If you would invest  810.00  in Talis Biomedical Corp on March 7, 2024 and sell it today you would earn a total of  119.00  from holding Talis Biomedical Corp or generate 14.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Talis Biomedical Corp  vs.  NanoVibronix

Talis Biomedical Corp

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Talis Biomedical Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating forward indicators, Talis Biomedical unveiled solid returns over the last few months and may actually be approaching a breakup point.

NanoVibronix

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NanoVibronix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Talis Biomedical and NanoVibronix

The main advantage of trading using opposite Talis Biomedical and NanoVibronix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talis Biomedical position performs unexpectedly, NanoVibronix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NanoVibronix will offset losses from the drop in NanoVibronix's long position.

The idea behind Talis Biomedical Corp and NanoVibronix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.